ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2019

T-cell bispecific antibodies in node-positive breast cancer: novel therapeutic avenue for MHC class I loss variants.

M Messaoudene et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.